The purpose of this study is to characterize three year descriptive growth and development
(ie, height, weight, body mass index, Tanner Stage) and efficacy of cholesterol reduction in
pediatric subjects with Heterozygous Familial Hypercholesterolemia receiving atorvastatin
treatment.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.